Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Icecure MedicalICCM +2.67%46 3-1 Month Momentum % is -44.27% as of Aug. 08, 2026. GuruFocus rates ICCM with a GF Score™ of 46/100 and a GF Value™ of $21.02 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 849 Medical Devices & Instruments companies, Icecure Medical ranks worse than 95.29% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-08), Icecure Medical's 3-1 Month Momentum % is -44.27%.
The industry rank for Icecure Medical's 3-1 Month Momentum % or its related term are showing as below:
ICCM's 3-1 Month Momentum % is ranked worse than 95.29% of 849
companies
in the Medical Devices & Instruments industry
Industry Median: -5.88
vs ICCM: -44.27
Icecure Medical (NAS:ICCM) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Icecure Medical 3-1 Month Momentum % Related Terms
ICCM vs NXL, ADGM, ALRTF: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Icecure Medical's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Icecure Medical 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Icecure Medical's 3-1 Month Momentum % falls into.
Icecure Medical (NAS:ICCM) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Icecure Medical (ICCM) has a 3-1 Month Momentum % of -44.27% as of Aug. 08, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Icecure Medical and its competitors. According to the industry distribution chart, Icecure Medical ranks #809 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 95.3%.
Is Icecure Medical's 3-1 Month Momentum % too high?
Icecure Medical's current 3-1 Month Momentum % is -44.27%. Based on the distribution chart, Icecure Medical ranks #809 out of 849 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Icecure Medical has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Icecure Medical's 3-1 Month Momentum % compare to NXL and ADGM?
According to the Medical Devices & Instruments industry distribution chart, Icecure Medical ranks #809 out of 849 companies for 3-1 Month Momentum %. This places Icecure Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Icecure Medical and its competitors. Icecure Medical's current 3-1 Month Momentum % is -44.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icecure Medical stock overvalued right now?
Based on GuruFocus' analysis, Icecure Medical (ICCM) is currently considered Possible Value Trap. The stock's GF Value™ is $21.02, compared to a current price of $3.08 — trading 85.3% below its estimated fair value. The current 3-1 Month Momentum % is -44.27%. Icecure Medical's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Icecure Medical (ICCM), the current 3-1 Month Momentum % is -44.27% as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Icecure Medical (ICCM) Overvalued in 2026?
Based on GuruFocus' analysis, Icecure Medical stock appears to be undervalued.
The current stock price of $3.08 is trading 85.3% below its estimated GF Value™ of $21.02.
GuruFocus considers Icecure Medical to be Possible Value Trap.
Key valuation signals for ICCM:
3-1 Month Momentum %: -44.27%
GF Value™: $21.02 vs. price of $3.08 (85.3% below fair value)
No single metric tells the full story. See the ICCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
46GF Score
Get the complete analysis for ICCM
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ICCM has been successfully added to your 
